Ritalin and Rasuvo drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ritalin and Rasuvo. Common interactions include anaemia among females.

The phase IV clinical study analyzes what interactions people who take Ritalin and Rasuvo have. It is created by eHealthMe based on reports of 6 people who take Ritalin and Rasuvo from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On May, 26, 2023

6 people who take Ritalin and Rasuvo together, and have interactions are studied.


What is Ritalin?

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 27,360 Ritalin users for its effectiveness, alternative drugs and more.

What is Rasuvo?

Rasuvo has active ingredients of methotrexate. It is often used in psoriatic arthritis. eHealthMe is studying from 3,158 Rasuvo users for its effectiveness, alternative drugs and more.

Number of Ritalin and Rasuvo reports submitted per year:

Ritalin and Rasuvo drug interactions.

Common Ritalin and Rasuvo drug interactions by gender *:

female:

  1. Anaemia
  2. Rheumatoid arthritis
  3. Pruritus
  4. Tendon pain
  5. Throat irritation
  6. Tendon rupture
  7. Thrombosis
  8. Anxiety
  9. Tooth abscess
  10. Asthenia

male:

n/a

Common Ritalin and Rasuvo drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anaemia
  2. Anxiety
  3. Drug ineffective
  4. Tooth abscess

40-49:

n/a

50-59:

n/a

60+:

  1. Anaemia
  2. Anaphylactic reaction
  3. Tendon pain
  4. Throat irritation
  5. Tendon rupture
  6. Thrombosis
  7. Drug ineffective
  8. Erythema nodosum
  9. Hypertension
  10. Insomnia

* Approximation only. Some reports may have incomplete information.

Do you take Ritalin and Rasuvo?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Ritalin and Rasuvo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ritalin side effects:

Browse all side effects of Ritalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rasuvo side effects:

Browse all side effects of Rasuvo:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ritalin interactions:

Browse all interactions between Ritalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rasuvo interactions:

Browse all interactions between Rasuvo and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on methylphenidate hydrochloride and methotrexate (the active ingredients of Ritalin and Rasuvo, respectively), and Ritalin and Rasuvo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Ritalin and Rasuvo.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: